scispace - formally typeset
F

Freddie Bray

Researcher at International Agency for Research on Cancer

Publications -  452
Citations -  345102

Freddie Bray is an academic researcher from International Agency for Research on Cancer. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 111, co-authored 402 publications receiving 262938 citations. Previous affiliations of Freddie Bray include University of Oslo.

Papers
More filters
Journal Article

A comparison of two methods to estimate the cancer incidence and mortality burden in China in 2005.

TL;DR: Li et al. as mentioned in this paper compared two methods of estimating national cancer-specific incidence and mortality in China 2005, based on the Third National Death Survey (method I) as compared with registry material (method II).
Journal ArticleDOI

Cancer incidence in northern Thailand: results from six population-based cancer registries 1993-2012.

TL;DR: In this article, a more detailed investigation of the incidence trends for specific cancer sites and subtypes at the local level are crucial to the monitoring and evaluation of the cancer control interventions implemented within the Thai national cancer control programme (NCCP).
Journal ArticleDOI

Cancer registration challenges in low- and middle-income countries-the case of the Pacific Islands.

TL;DR: This paper presents a meta-analyses of the literature review and meta-analysis conducted at the 2015 World Health Organization (WHO) conference on quantitative and qualitative determinants of cancer progression in smokers and non-smokers.
Journal ArticleDOI

The future burden of cancer in London compared with England

TL;DR: The future burden of cancer in London and England is estimated and ASRs for all cancers (excluding non-melanoma skin cancer) decreased for both sexes, whereas in England, ASRs decreased in males and increased slightly in females.
Journal ArticleDOI

Pancreatic cancer: an increasing global public health concern.

TL;DR: In this article, a comprehensive risk prediction model supporting earlier diagnosis of pancreatic cancer was proposed, which is all the more valid given the poor prognosis and rising mortality of PC in many settings and the present gaps in understanding of the underlying causes of the increase.